• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-199通过调节上皮-间质转化抑制干性,从而逆转胰腺癌对吉西他滨的耐药性。

MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition.

作者信息

Wei Weitian, Wang Liang, Xu Liwei, Liang Jinxiao, Teng Lisong

机构信息

Department of Surgical Oncology, Zhejiang University School of Medicine First Affiliated Hospital, No. 79 Qingchun Road, Shangcheng District, Hangzhou 310009, China.

Department of Surgical Oncology, Zhejiang Cancer Hospital, No. 1, East Banshan Road, Gongshu District, Hangzhou 310022, China.

出版信息

ACS Omega. 2021 Nov 17;6(47):31435-31446. doi: 10.1021/acsomega.1c02945. eCollection 2021 Nov 30.

DOI:10.1021/acsomega.1c02945
PMID:34869970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8637594/
Abstract

PURPOSE

the present study aims to investigate the function of miR-199 on gemcitabine (GEM)-resistance in pancreatic cancer, as well as the underlying mechanism.

METHODS

the GEM-resistant SW1990 cell line (SW1990/SZ) was established. The CCK-8 assay was used to detect the cell viability. The self-renewal of SW1990/SZ cells was evaluated by sphere formation and the colony formation assay. The apoptosis was detected by flow cytometry and the migration ability was measured by the transwell assay. The dual-luciferase gene reporter assay was utilized to confirm the binding between miR-199 and Snail. The expression level of CD44, ALDH1, Nanog, E-cadherin, Vimentin, β-catenin, and Snail was determined by the Western blotting assay.

RESULTS

the cell sphere formation rate, number of spheres, and expression level of CD44, ALDH1, and Nanog in GEM-treated SW1990/SZ cells were significantly suppressed by miR-199, accompanied by declined proliferation ability, an increased apoptotic rate, inhibited migration ability, and suppressed EMT progression. The binding site between miR-199 and 3'-UTR of Snail was predicted and confirmed. The inhibitory effect of miR-199 on self-renewal of SW1990/GZ cells and the faciliating property of miR-199 on the inhibitory effect of GEM against the proliferation ability, migration ability, and EMT progression were abolished by overexpressing Snail.

CONCLUSION

MiR-199 reversed the resistance to GEM in pancreatic cancer by suppressing stemness through regulating the EMT.

摘要

目的

本研究旨在探讨miR-199在胰腺癌吉西他滨(GEM)耐药中的作用及其潜在机制。

方法

建立GEM耐药的SW1990细胞系(SW1990/SZ)。采用CCK-8法检测细胞活力。通过成球实验和集落形成实验评估SW1990/SZ细胞的自我更新能力。采用流式细胞术检测细胞凋亡,采用Transwell实验检测细胞迁移能力。利用双荧光素酶基因报告实验证实miR-199与Snail之间的结合。采用蛋白质印迹法检测CD44、ALDH1、Nanog、E-钙黏蛋白、波形蛋白、β-连环蛋白和Snail的表达水平。

结果

miR-199显著抑制GEM处理的SW1990/SZ细胞的细胞成球率、球状体数量以及CD44、ALDH1和Nanog的表达水平,同时伴随着增殖能力下降、凋亡率增加、迁移能力抑制和上皮-间质转化(EMT)进程受抑制。预测并证实了miR-199与Snail的3'-UTR之间的结合位点。过表达Snail消除了miR-199对SW1990/GZ细胞自我更新的抑制作用以及miR-199对GEM抑制增殖能力、迁移能力和EMT进程的促进作用。

结论

MiR-199通过调节EMT抑制干性,从而逆转胰腺癌对GEM的耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/baecf5175048/ao1c02945_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/8941a2353cd9/ao1c02945_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/bd2db4379e4e/ao1c02945_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/b3afcae1a38f/ao1c02945_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/c000275b150f/ao1c02945_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/6c5eb55914ac/ao1c02945_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/3835f1f50a63/ao1c02945_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/b1f737d4a929/ao1c02945_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/3be337405d56/ao1c02945_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/baecf5175048/ao1c02945_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/8941a2353cd9/ao1c02945_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/bd2db4379e4e/ao1c02945_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/b3afcae1a38f/ao1c02945_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/c000275b150f/ao1c02945_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/6c5eb55914ac/ao1c02945_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/3835f1f50a63/ao1c02945_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/b1f737d4a929/ao1c02945_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/3be337405d56/ao1c02945_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e939/8637594/baecf5175048/ao1c02945_0010.jpg

相似文献

1
MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition.微小RNA-199通过调节上皮-间质转化抑制干性,从而逆转胰腺癌对吉西他滨的耐药性。
ACS Omega. 2021 Nov 17;6(47):31435-31446. doi: 10.1021/acsomega.1c02945. eCollection 2021 Nov 30.
2
Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition.大黄素通过调节上皮-间质转化抑制干性,从而逆转胰腺癌对吉西他滨的耐药性。
Exp Ther Med. 2022 Nov 16;25(1):7. doi: 10.3892/etm.2022.11706. eCollection 2023 Jan.
3
Cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer.在胰腺癌缺氧条件下,肿瘤相关成纤维细胞通过 HIF-1α/miR-21 轴促进干性维持和吉西他滨耐药。
Mol Carcinog. 2024 Mar;63(3):524-537. doi: 10.1002/mc.23668. Epub 2024 Jan 10.
4
Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway.冬凌草甲素通过抑制Wnt/β-连环蛋白信号通路抑制胰腺癌细胞迁移和上皮-间质转化。
Cancer Cell Int. 2016 Jul 22;16:57. doi: 10.1186/s12935-016-0336-z. eCollection 2016.
5
The Effects of HSP27 on Gemcitabine-Resistant Pancreatic Cancer Cell Line Through Snail.热休克蛋白27通过Snail对吉西他滨耐药胰腺癌细胞系的影响
Pancreas. 2015 Oct;44(7):1121-9. doi: 10.1097/MPA.0000000000000418.
6
MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.MicroRNA-300 通过靶向胰腺癌细胞中的 CUL4B 促进细胞凋亡,抑制增殖、迁移、侵袭和上皮-间充质转化,通过 Wnt/β-catenin 信号通路。
J Cell Biochem. 2018 Jan;119(1):1027-1040. doi: 10.1002/jcb.26270. Epub 2017 Aug 23.
7
Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.上皮间质转化与胰腺癌中的 CD24+CD44+和 CD133+细胞相关。
Oncol Rep. 2012 May;27(5):1599-605. doi: 10.3892/or.2012.1681. Epub 2012 Feb 7.
8
[Regulatory effect of miR-30b on migration and invasion of pancreatic cancer stem cells].[miR-30b对胰腺癌干细胞迁移和侵袭的调控作用]
Zhonghua Yi Xue Za Zhi. 2019 Oct 15;99(38):3019-3023. doi: 10.3760/cma.j.issn.0376-2491.2019.38.011.
9
[The relationship between the radioresistance of pancreatic cancer cell SW1990 and the induction of the Epithelial-Mesenchymal Transition: an in vitro study].
Zhonghua Yi Xue Za Zhi. 2018 Mar 27;98(12):939-943. doi: 10.3760/cma.j.issn.0376-2491.2018.12.013.
10
miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.miR-485-5p 通过负向调控 MUC1 抑制乳腺癌细胞的进展。
Breast Cancer. 2020 Jul;27(4):765-775. doi: 10.1007/s12282-020-01075-2. Epub 2020 Mar 6.

引用本文的文献

1
MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells.微小RNA作为胰腺肿瘤细胞上皮-间质转化的关键调节因子
Heliyon. 2024 May 1;10(9):e30599. doi: 10.1016/j.heliyon.2024.e30599. eCollection 2024 May 15.
2
ALDH1: A potential therapeutic target for cancer stem cells in solid tumors.醛脱氢酶1:实体瘤中癌症干细胞的潜在治疗靶点。
Front Oncol. 2022 Oct 28;12:1026278. doi: 10.3389/fonc.2022.1026278. eCollection 2022.

本文引用的文献

1
Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.来源于吉西他滨耐药胰腺癌肿瘤干细胞的外泌体通过传递 miR-210 增强药物耐药性。
Cell Oncol (Dordr). 2020 Feb;43(1):123-136. doi: 10.1007/s13402-019-00476-6. Epub 2019 Nov 12.
2
MiR-199 inhibits EMT and invasion of hepatoma cells through inhibition of Snail expression.miR-199 通过抑制 Snail 表达抑制肝癌细胞 EMT 和侵袭。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7884-7891. doi: 10.26355/eurrev_201909_18998.
3
Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions.
当前胰腺癌治疗的临床策略和未解决的分子问题。
Int J Mol Sci. 2019 Sep 13;20(18):4543. doi: 10.3390/ijms20184543.
4
Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.miRNA 调控的癌症干细胞在人类恶性肿瘤发病机制中的作用。
Cells. 2019 Aug 5;8(8):840. doi: 10.3390/cells8080840.
5
ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer.ROS/KRAS/AMPK信号通路促成吉西他滨诱导的胰腺癌干细胞样特性
Mol Ther Oncolytics. 2019 Aug 9;14:299-312. doi: 10.1016/j.omto.2019.07.005. eCollection 2019 Sep 27.
6
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.上皮-间质转化(EMT)与癌症干细胞:对胰腺癌治疗耐药性的影响
Mol Cancer. 2017 Feb 28;16(1):52. doi: 10.1186/s12943-017-0624-9.
7
Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.上皮间质转化的多种途径与癌症的进展和转移有关,以及内分泌干扰物对上皮间质转化过程的潜在影响。
Mol Cell Endocrinol. 2017 Dec 5;457:103-113. doi: 10.1016/j.mce.2016.12.026. Epub 2016 Dec 29.
8
Aldehyde dehydrogenase 1A1 in stem cells and cancer.干细胞与癌症中的乙醛脱氢酶1A1
Oncotarget. 2016 Mar 8;7(10):11018-32. doi: 10.18632/oncotarget.6920.
9
Gemcitabine resistance in pancreatic ductal adenocarcinoma.胰腺导管腺癌中的吉西他滨耐药性。
Drug Resist Updat. 2015 Nov;23:55-68. doi: 10.1016/j.drup.2015.10.002. Epub 2015 Nov 3.
10
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.简明综述:CD44在癌症干细胞中的新兴作用:一种有前景的生物标志物和治疗靶点
Stem Cells Transl Med. 2015 Sep;4(9):1033-43. doi: 10.5966/sctm.2015-0048. Epub 2015 Jul 1.